Clinical Trial

A Clinical Study of KLH-2109 in Patients With Endometriosis

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
To verify the non-inferiority of KLH-2109 to leuprorelin acetate in a double-blind manner in terms of efficacy in endometriosis patients with pelvic pain.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-06-03; most recent amendment 2026-02-27.
Status change: Recruiting → Active, Not Recruiting 2026-02-27
Trial Details
NCT Number NCT07015268
Lead Sponsor Kissei Pharmaceutical Co., Ltd.
Conditions Endometriosis
Enrollment 288 participants
Start Date 2025-06-09
Primary Completion 2027-11 (estimated)
Study Completion 2027-11 (estimated)
Updated on ClinicalTrials.gov 2026-03-02